Business Wire
19 Nov 2026, 08:30 UTC · 10h ago
Jacobs selected by Sanofi to deliver new insulin manufacturing facility in Germany
Impact · against what's priced in
Jacobs gains a material contract win as EPCM partner for Sanofi's new German facility, boosting its industrial backlog. Sanofi demonstrates continued capacity expansion in its insulin portfolio, though the impact on its valuation is marginal compared to the project win for Jacobs.
- JKG+0.20
No priced-in read yet





